cerebellar dysplastic gangliocytoma
GPTKB entity
Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
neoplasm
|
| gptkbp:advertising |
educational resources
community outreach fundraising events |
| gptkbp:advocacy |
public awareness
research funding policy change |
| gptkbp:aftermath |
rare
|
| gptkbp:ageLimit |
childhood
|
| gptkbp:associatedWith |
neurodevelopmental disorders
|
| gptkbp:caseOutcome |
variable
|
| gptkbp:classification |
WHO grade I
|
| gptkbp:clinicalTrials |
ongoing
completed recruiting phase II phase III |
| gptkbp:diseaseResistance |
MRI
variable biopsy astrocytoma ependymoma medulloblastoma |
| gptkbp:geneticDiversity |
chromosomal abnormalities
|
| gptkbp:hasPopulation |
children
young adults |
| https://www.w3.org/2000/01/rdf-schema#label |
cerebellar dysplastic gangliocytoma
|
| gptkbp:impact |
surgery
radiation therapy chemotherapy |
| gptkbp:location |
cerebellum
|
| gptkbp:researchFocus |
genetic factors
treatment efficacy long-term outcomes |
| gptkbp:riskManagement |
environmental factors
genetic predisposition |
| gptkbp:runnerUp |
imaging studies
neurological assessment symptom management |
| gptkbp:structureType |
gangliocytoma
|
| gptkbp:supports |
online forums
patient advocacy organizations local support groups |
| gptkbp:symptoms |
seizures
ataxia headaches |
| gptkbp:type |
brain tumor
|